Profile

Chain Biotech Ltd

CHAIN Biotechnology Ltd was founded by Dr Edward Green in 2014 to develop new Clostridium-based microbial technology for high value healthcare products. CHAIN produces novel live biotherapeutic products (LBPs) for chronic gut-related diseases, such as Inflammatory Bowel Disease (IBD).

At the heart of CHAIN’s unique therapeutic platform is a suite of underpinning technologies including a Clostridia culture collection, a proprietary set of plasmid vectors, synthetic biology tools for advanced metabolic engineering, and an advanced in-vivo delivery mechanism using Clostridium.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website chainbiotech.com/

Associated Team Members

Relevant News

CHAIN Wins Grants to Expand Platform

CHAIN has been awarded two grants to support its therapeutic delivery platform from Innovate...

read more

CHAIN Awarded EuropaBio Membership

NOTTINGHAM, UK. — January 9th, 2019 — CHAIN has joined EuropaBio as a full...

read more

A New Home

In November, CHAIN moved research base from the University of Nottingham into independent lab...

read more

CHAIN Features in Engineering Biology Explained

CHAIN features in a new explainer document on engineering biology from the UK Bioindustry...

read more

CHAIN at Microbiome Conferences in June

CHAIN Chief Executive Dr Edward Green will be speaking at the 2nd Annual Microbiome...

read more

CHAIN to Explore Manufacturing of Novel Medicines

UK biotech to manufacture novel medicines for Inflammatory Bowel Disease using spores of gut...

read more

More Companies in Medical / Biotechnology